Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two -Stage First in Human (FIH) Feasibility / Pivotal Study of the Vienna Aortic Valve SE System

NCT04861805 is registered in ClinicalTrials.gov with P+F Products + Features GmbH as lead sponsor.

NCT NCT04861805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04861805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two -Stage First in Human (FIH) Feasibility / Pivotal Study of the Vienna Aortic Valve SE System
Lead sponsor
P+F Products + Features GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
July 3, 2023
Completion date
October 31, 2030
Enrollment
267 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic aortic stenosis